Feed POLBF
PO

Poolbeg Pharma PLC

POLBF · OTC

$0.10 +0.00% (+$0.00)
Market Cap £54.2M
P/E Ratio -
Div. Yield -
ROE 53.90%
Piotroski F-Score Weak
1/9
Valuation
21 /100
Expensive
P/B 6.30x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining
Book val. growth 22.29%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A
Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor
ROE 53.90%
ROA 57.28%
Asset turnover 0.00x
Debt
100 /100
Low
Current ratio 6.17x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
27 /100
Unstable
EPS volatility 37.15%
Profitable years 0
Beta 1.81x

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about POLBF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Jeremy Skillington

Employees

15

Headquarters

London

Upcoming events

04 MAR

Earnings

Upcoming earnings report

164d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.